Anika Mang

Title: Anika Mang: Innovator in Heart Failure Diagnosis

Introduction

Anika Mang is a prominent inventor based in Mannheim, Germany. She has made significant contributions to the field of medical diagnostics, particularly in the area of heart failure. Her innovative work has the potential to improve patient outcomes and enhance the accuracy of heart failure diagnoses.

Latest Patents

Anika Mang holds a patent for her invention titled "IGFBP7 ratio for HFpEF." This invention relates to a method for differentiating between heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF). The method involves determining the amounts of IGFBP7 (Insulin-like growth factor-binding protein 7), a BNP-type peptide, and optionally CRP (C-reactive protein) in a sample from the subject. By calculating specific ratios and comparing them with reference values, the method aims to accurately diagnose HFpEF.

Career Highlights

Anika Mang is currently employed at Roche Diagnostics Operations, Inc., where she continues to develop innovative solutions in the field of diagnostics. Her work is characterized by a commitment to advancing medical technology and improving patient care.

Collaborations

Anika collaborates with notable colleagues, including Kai Habben and Vinzent Rolny. These partnerships enhance her research and contribute to the development of groundbreaking diagnostic methods.

Conclusion

Anika Mang's contributions to heart failure diagnostics exemplify the impact of innovation in medicine. Her patent for the IGFBP7 ratio method represents a significant advancement in the field, showcasing her dedication to improving healthcare outcomes.